Is NAD+ the real deal—or just another overhyped trend in the chronic illness space?

In this episode of The Talk by The disABLED Company, we dig into the science behind NAD+ and its potential role in treating muscle-based autoimmune diseases like Inclusion Body Myositis (IBM), Multiple Sclerosis (MS), and Idiopathic Inflammatory Myopathies (IIM).

We break it down:

• What NAD+ is and how it works
• What current research says about its impact on inflammation, energy, and recovery
• And whether this treatment is worth your time (and your money)

💡 Created with support from Google LM to help synthesize research, but the real voice? That’s all me.

👉 Listen now and decide for yourself: breakthrough or just buzz?

Alicia D. Polak
Chief Enabled Officer
Email: [email protected]
Instagram: @aliciathedisabledcompany.com
Website: www.thedisabledcompany.com